vs

Side-by-side financial comparison of Akebia Therapeutics, Inc. (AKBA) and RMR GROUP INC. (RMR). Click either name above to swap in a different company.

RMR GROUP INC. is the larger business by last-quarter revenue ($66.7M vs $57.6M, roughly 1.2× Akebia Therapeutics, Inc.). On growth, RMR GROUP INC. posted the faster year-over-year revenue change (40.8% vs 23.9%).

Akebia Therapeutics is a biopharmaceutical company dedicated to developing and commercializing novel therapies for patients with kidney diseases, particularly anemia linked to chronic kidney disease. It operates across global markets, focusing on addressing unmet medical needs in the nephrology care segment.

RMR Group Inc. is a U.S.-headquartered alternative asset management firm specializing in real estate and real estate-related investments. It operates across commercial property, residential real estate, and infrastructure segments, serving institutional investors, high-net-worth individuals, and retail clients across key global markets.

AKBA vs RMR — Head-to-Head

Bigger by revenue
RMR
RMR
1.2× larger
RMR
$66.7M
$57.6M
AKBA
Growing faster (revenue YoY)
RMR
RMR
+16.8% gap
RMR
40.8%
23.9%
AKBA

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AKBA
AKBA
RMR
RMR
Revenue
$57.6M
$66.7M
Net Profit
$12.2M
Gross Margin
78.2%
Operating Margin
-14.8%
48.1%
Net Margin
18.3%
Revenue YoY
23.9%
40.8%
Net Profit YoY
91.1%
EPS (diluted)
$-0.05
$0.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AKBA
AKBA
RMR
RMR
Q4 25
$57.6M
$66.7M
Q3 25
$58.8M
Q2 25
$62.5M
Q1 25
$57.3M
Q4 24
$46.5M
Q3 24
$37.4M
Q2 24
$43.6M
Q1 24
$32.6M
Net Profit
AKBA
AKBA
RMR
RMR
Q4 25
$12.2M
Q3 25
$540.0K
Q2 25
$247.0K
Q1 25
$6.1M
Q4 24
Q3 24
$-20.0M
Q2 24
$-8.6M
Q1 24
$-18.0M
Gross Margin
AKBA
AKBA
RMR
RMR
Q4 25
78.2%
Q3 25
84.0%
Q2 25
84.1%
Q1 25
86.7%
Q4 24
56.2%
Q3 24
62.2%
Q2 24
60.9%
Q1 24
64.4%
Operating Margin
AKBA
AKBA
RMR
RMR
Q4 25
-14.8%
48.1%
Q3 25
7.6%
Q2 25
22.6%
Q1 25
23.6%
Q4 24
-30.8%
Q3 24
-33.4%
Q2 24
-20.0%
Q1 24
-45.8%
Net Margin
AKBA
AKBA
RMR
RMR
Q4 25
18.3%
Q3 25
0.9%
Q2 25
0.4%
Q1 25
10.7%
Q4 24
Q3 24
-53.5%
Q2 24
-19.7%
Q1 24
-55.2%
EPS (diluted)
AKBA
AKBA
RMR
RMR
Q4 25
$-0.05
$0.71
Q3 25
$0.00
Q2 25
$0.00
Q1 25
$0.03
Q4 24
$-0.10
Q3 24
$-0.10
Q2 24
$-0.04
Q1 24
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AKBA
AKBA
RMR
RMR
Cash + ST InvestmentsLiquidity on hand
$184.8M
$49.3M
Total DebtLower is stronger
$48.3M
Stockholders' EquityBook value
$32.6M
$232.7M
Total Assets
$376.6M
$687.1M
Debt / EquityLower = less leverage
1.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AKBA
AKBA
RMR
RMR
Q4 25
$184.8M
$49.3M
Q3 25
$166.4M
Q2 25
$137.3M
Q1 25
$113.4M
Q4 24
$51.9M
Q3 24
$34.0M
Q2 24
$39.5M
Q1 24
$42.0M
Total Debt
AKBA
AKBA
RMR
RMR
Q4 25
$48.3M
Q3 25
$47.6M
Q2 25
$47.1M
Q1 25
$46.5M
Q4 24
$38.7M
Q3 24
$38.4M
Q2 24
$38.0M
Q1 24
$30.1M
Stockholders' Equity
AKBA
AKBA
RMR
RMR
Q4 25
$32.6M
$232.7M
Q3 25
$41.6M
Q2 25
$29.2M
Q1 25
$24.6M
Q4 24
$-49.2M
Q3 24
$-50.4M
Q2 24
$-33.8M
Q1 24
$-27.3M
Total Assets
AKBA
AKBA
RMR
RMR
Q4 25
$376.6M
$687.1M
Q3 25
$364.2M
Q2 25
$345.6M
Q1 25
$310.2M
Q4 24
$220.7M
Q3 24
$207.1M
Q2 24
$220.2M
Q1 24
$225.5M
Debt / Equity
AKBA
AKBA
RMR
RMR
Q4 25
1.48×
Q3 25
1.15×
Q2 25
1.61×
Q1 25
1.89×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AKBA
AKBA
RMR
RMR
Operating Cash FlowLast quarter
$31.1M
$10.7M
Free Cash FlowOCF − Capex
$31.1M
FCF MarginFCF / Revenue
53.9%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
0.88×
TTM Free Cash FlowTrailing 4 quarters
$67.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AKBA
AKBA
RMR
RMR
Q4 25
$31.1M
$10.7M
Q3 25
$28.1M
Q2 25
$22.3M
Q1 25
$-13.6M
Q4 24
$-4.5M
Q3 24
$-6.7M
Q2 24
$-10.1M
Q1 24
$-19.4M
Free Cash Flow
AKBA
AKBA
RMR
RMR
Q4 25
$31.1M
Q3 25
$28.0M
Q2 25
$22.2M
Q1 25
$-13.6M
Q4 24
$-4.5M
Q3 24
$-6.7M
Q2 24
$-10.1M
Q1 24
FCF Margin
AKBA
AKBA
RMR
RMR
Q4 25
53.9%
Q3 25
47.7%
Q2 25
35.6%
Q1 25
-23.7%
Q4 24
-9.6%
Q3 24
-17.9%
Q2 24
-23.1%
Q1 24
Capex Intensity
AKBA
AKBA
RMR
RMR
Q4 25
0.1%
Q3 25
0.1%
Q2 25
0.2%
Q1 25
0.0%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.1%
Q1 24
0.0%
Cash Conversion
AKBA
AKBA
RMR
RMR
Q4 25
0.88×
Q3 25
52.05×
Q2 25
90.47×
Q1 25
-2.22×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AKBA
AKBA

Auryxia$48.1M84%
Vafseo$6.2M11%
License Collaboration And Other Revenue$3.3M6%

RMR
RMR

Management Service Incentive$23.6M35%
Industrial Logistics Properties Trust$15.1M23%
Managed Private Real Estate Capital$11.1M17%
Office Properties Income Trust$5.6M8%
Other Private Entities$5.3M8%
RMR Residential$3.4M5%
Sonesta International Hotels Corporation$2.1M3%
Investment Advisory Management And Administrative Service$1.2M2%

Related Comparisons